Docstoc

2012 Aarkstore.com || Bayer AG – Product Pipeline Review – 2012

Document Sample
2012 Aarkstore.com || Bayer AG – Product Pipeline Review – 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Bayer AG – Product Pipeline Review – 2012




You can also request for sample page of above mention reports on
sample@aarkstore.com

Summary

Global Market Direct’s pharmaceuticals report, “Bayer AG - Product Pipeline Review
- 2012” provides data on the Bayer AG’s research and development focus. The
report includes information on current developmental pipeline, complete with latest
updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Bayer AG’s corporate website, SEC filings, investor
presentations and featured press releases, both from Bayer AG and industry-specific
third party sources, put together by Global Markets Direct’s team.

Scope

- Bayer AG - Brief Bayer AG overview including business description, key
information and facts, and its locations and subsidiaries.
- Review of current pipeline of Bayer AG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.

Table of contents:

List of Tables 13
List of Figures 16
Bayer AG Snapshot 17
Bayer AG Overview 17
Key Information 17
Key Facts 17
Bayer AG – Research and Development Overview 18
Key Therapeutic Areas 18
Bayer AG – Pipeline Review 23
Pipeline Products by Stage of Development 23
Pipeline Products – Monotherapy 24
Pipeline Products – Combination Treatment Modalities 25
Bayer AG – Pipeline Products Glance 26
Bayer AG – Late Stage Pipeline 26
Registration Filed Products/Combination Treatment Modalities 26
Phase III Products/Combination Treatment Modalities 27
Bayer AG Clinical Stage Pipeline Products 29
Phase II Products/Combination Treatment Modalities 29
Phase I Products/Combination Treatment Modalities 32
Bayer AG – Early Stage Pipeline Products 34
Pre-Clinical Products/Combination Treatment Modalities 34
Bayer AG – Drug Profiles 35
Alpharadin 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Amikacin Inhale 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Autologous FL Vaccine 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
BAY 1000394 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
BAY 1002670 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
BAY 80-6946 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
BAY 80-6946 + Paclitaxel 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Eylea 72
Product Description 72
Mechanism of Action 72



List of Figures

List of Tables are also include.




For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1




Ardea Biosciences, Inc. – Product Pipeline Review – 2012

Astellas Pharma Inc. – Product Pipeline Review – 2012
Bayer AG – Product Pipeline Review – 2012

BioLineRx, Ltd. – Product Pipeline Review – 2012

Cytokinetics, Incorporated – Product Pipeline Review – 2012

Meda AB – Product Pipeline Review – 2012

Medivir AB – Product Pipeline Review – 2012

Nektar Therapeutics – Product Pipeline Review – 2012

Novo Nordisk A/S – Product Pipeline Review – 2012

SciClone Pharmaceuticals, Inc. – Product Pipeline Review – 2012




Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585
Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:5
posted:8/24/2012
language:
pages:5
Description: Global Market Direct’s pharmaceuticals report, “Bayer AG - Product Pipeline Review - 2012” provides data on the Bayer AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.